Elsevier

Vaccine

Volume 39, Issue 41, 1 October 2021, Pages 6037-6040
Vaccine

Prenatal maternal COVID-19 vaccination and pregnancy outcomes

https://doi.org/10.1016/j.vaccine.2021.09.012Get rights and content

Highlights

  • Although not tested on pregnant women, prenatal COVID-19 vaccination is recommended.

  • It is critical to address the effects of prenatal vaccination on pregnancy outcomes.

  • Pregnant women are less adherent with the recommendations.

  • Prenatal COVID-19 vaccination is not associated with adverse pregnancy outcomes.

  • Current results may help pregnant women make informed consent regarding vaccination.

Abstract

Background

Prenatal maternal physiological changes may cause severe COVID-19 among pregnant women. The Pfizer-BioNTech COVID-19 vaccine (BNT162b2 mRNA) has been shown to be highly effective and it is recommended for individuals aged ≥16 years, including pregnant women, although the vaccine has not been tested on the latter.

Objective

To study the association between prenatal Pfizer-BioNTech COVID-19 vaccination, pregnancy course and outcomes.

Study design

A retrospective cohort study was performed, including all women who delivered between January and June 2021 at Soroka University Medical Center, the largest birth center in Israel. Excluded were women diagnosed with COVID-19 in the past, multiple gestations or unknown vaccination status. Pregnancy, delivery and newborn complications were compared between women who received 1 or 2-dose vaccines during pregnancy and unvaccinated women. Multivariable models were used to adjust for background characteristics.

Results

A total of 4,399 women participated in this study, 913 (20.8%) of which were vaccinated during pregnancy. All vaccinations occurred during second or third trimesters. As compared to the unvaccinated women, vaccinated women were older, more likely to conceive following fertility treatments, to have sufficient prenatal care, and of higher socioeconomic position. In both crude and multivariable analyses, no differences were found between the groups in pregnancy, delivery and newborn complications, including gestational age at delivery, incidence of small for gestational age and newborn respiratory complications.

Conclusions

Prenatal maternal COVID-19 vaccine has no adverse effects on pregnancy course and outcomes. These findings may help pregnant women and health care providers to make informed decision regarding vaccination.

Keywords

Covid-19
Pfizer-BioNTech COVID-19 vaccination
Pregnancy outcomes

Cited by (0)

View Abstract